期刊文献+

胰腺癌早期和术后相关性指标的临床研究 被引量:1

Clinical research of relativity index with pancreatic cancer prophase and postoperation
下载PDF
导出
摘要 目的研究一组具有高度敏感性和特异性的血清标记物,能够早期诊断胰腺癌和监测胰腺癌术后疗效。方法收集病例100例分为三组,第一组:50例正常人为阴性对照组;第二组:50例经临床确诊为胰腺癌组;第三组:在第二组术后1个月为监测组。然后,分别对它们采取血液进行AFP、CEA、CA199、CA153、CA125及CA50、POA、PCAA的定量检测,研究其阳性率、敏感性和特异性。结果第一组的8种指标均为阴性,无显著性差异(P>0.05)。第二组中的8种指标浓度水平明显升高,与第一组相比,具有高敏感性和高特异性,x2值分别为18.7和15.1,具有显著性差异P<0.05。第三组与第二组相比,8种指标浓度水平明显下降至正常水平,P<0.01,具有显著性差异。结论当胰腺癌变时,8种相关性指标可作为一组高度敏感性和特异性的血清标记物,同时也可作为胰腺癌术后疗效的一组监测指标。 Objective To study a group serum markers with high sensitivity and specificity,it can earlydiagnose pancreatic cancer and survey postoperative efficacy of pancreatic cancer. Methods 100 cases were collected and divided into three groups.The first group was nega-tive control group for 50 cases of normal people.The second group was pancreatic cancer group for 50 cases clinically diagnosed to pancreatic cancer.The third group was monitoring group for the second group postoperative one month.Then they were respectively took blood into detect concentration level of AFP,CEA,CA199,CA153,CA125,CA50,POA,PCAA and studied its positive rate, sensitivity and specificity. Results Eight kinds of index in the first group were also negative.The P values were greater than 0.05.They showed no significant difference.Eight kinds of index concentration levels in patients with the second group increas-ed significantly.Compared with the first group,they had high sensitivity and high specificity.The x^2 values respectively were 18.7 and 15.1,The P values was inferior to 0.05.They show-ed significant difference.The third group compared with the second group.Eight kinds of index concentration levels significantly decreased to normal level.The P values were also inferior to 0.01.They showed significant difference. Conclusion As pancreas took place canceration eight kinds of correlation index can be used as a group of blood markers with high sensitivity and specificity.At the same time also it can be usedas a group of monitoringindex of pancreatic cancer postoperative efficacy.
出处 《中国医药科学》 2013年第15期114-115,130,共3页 China Medicine And Pharmacy
基金 2013年度广东省汕头市医疗科技计划项目
关键词 CA50 胰腺癌胚抗原 胰腺癌相关抗原 CASO Pancreatic antigen Pancreatic ceneer associated antigen
  • 相关文献

参考文献6

  • 1吴在德.外科学[M].第7版.北京:人民卫生出版社,2012:193-194.
  • 2Everhart J,Wright D.Diabetes mellitus as a risk factor for pancreaticcancer[J].JAMA,2011,273(20):1605-1609.
  • 3Tada M,Teratanl T,Konatgu Y,et al.Quantitative analysis of ras genemutation in pancreatic juice for diagnose of pancreatic adenocarcinoma[J].Digestive Disease and Sciences,2010,143(IB):15-20.
  • 4陆再英,叶任高.内科学[M].第7版.北京:人民卫生出版社,2012:777.
  • 5Bhattacharyya S,Siegel RR,Petersen GM,et al.Diagnosis of pancreaticcancer using serum proteomic profiling[J].Neoplasia,2010,126(12):674-686.
  • 6Coggins M.Molecular markers of early pancreatic cancer[J].J Clin Oncol,2012,123(25):.4524^531.

共引文献66

同被引文献21

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部